Clinical Trials on Safety、Immunogenicity in Finland
Total 13 results
-
Vesa JuutilainenRecruiting
-
Avena Nordic Grain OyCompleted
-
Gabather ABSmerud Medical Research International ASCompletedSafety and TolerabilityFinland
-
Avilex PharmaCompletedTolerance | Safety IssuesFinland
-
Women and Infants Hospital of Rhode IslandAgency for Healthcare Research and Quality (AHRQ)UnknownPatient Safety | Organizational ChangeUnited States
-
EstetraCompletedSafetyEstonia, Finland, Georgia, Latvia, Poland, Sweden
-
VTT Technical Research Centre of FinlandUniversity of Eastern FinlandCompletedSubjective Appetite and SatietyFinland
-
Brandeis UniversityNational Institute on Drug Abuse (NIDA); Oregon Health and Science University; University of Washington and other collaboratorsActive, not recruitingOpioid Use | Patient Safety | PharmaciesUnited States
-
LifespanCompletedInjuries | Safety Issues | Car AccidentUnited States
-
Biotronik, Inc.CompletedSafety of the ProMRI Pacemaker System Under Specific MRI ConditionsUnited States
-
Novartis PharmaceuticalsUniversity of PennsylvaniaRecruitingLong Term Safety of Patients Receiving CAR-T in an Eligible Clinical Trial or Managed Access ProgramUnited States, Japan, Australia, Germany, Spain, Belgium, Taiwan, Italy, Canada, Israel, Singapore, United Kingdom, Denmark, Finland, Norway, Austria, Netherlands, France
-
University of FloridaNational Institute on Aging (NIA)RecruitingMentoring | Accidental Fall | Hospital Acquired Condition | Patient Safety | Clinical AlarmsUnited States
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)Active, not recruitingNausea | Constipation | Diarrhea | Purpura | Lymphadenopathy | Gastrointestinal Hemorrhage | Hepatomegaly | Primary Systemic Amyloidosis | Amorphous, Eosinophilic, and Acellular Deposit | Early Satiety | Macroglossia | Recurrent Primary Amyloidosis | Refractory Primary AmyloidosisUnited States